Acumen Pharmaceuticals, Inc.
ABOS
$2.72
$0.041.49%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -121.34M | -133.35M | -136.67M | -116.25M | -102.33M |
| Total Depreciation and Amortization | 184.00K | 183.00K | 181.00K | 179.00K | 178.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.73M | 9.40M | 7.85M | 5.24M | 4.28M |
| Change in Net Operating Assets | -5.12M | 108.00K | 10.87M | 8.36M | 11.65M |
| Cash from Operations | -115.54M | -123.66M | -117.76M | -102.48M | -86.22M |
| Capital Expenditure | -88.00K | -88.00K | -88.00K | -84.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.02M | 137.43M | 86.79M | 86.00M | 48.04M |
| Cash from Investing | 133.93M | 137.35M | 86.70M | 85.92M | 48.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -739.00K |
| Issuance of Common Stock | 39.00K | 37.00K | 37.00K | 37.00K | 7.94M |
| Repurchase of Common Stock | -73.00K | -82.00K | -82.00K | -82.00K | -41.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -42.00K | -170.00K | -230.00K |
| Cash from Financing | -34.00K | -45.00K | -87.00K | -215.00K | 6.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.36M | 13.64M | -31.15M | -16.77M | -31.26M |